Article info

Download PDFPDF

Short report
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
Free

Authors

  1. Correspondence to Dr Marton König, Department of Neurology, Oslo University Hospital, 0424 Oslo, Norway; makoni{at}ous-hf.no
View Full Text

Citation

König M, Lorentzen ÅR, Torgauten HM, et al
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations

Publication history

  • Received July 14, 2021
  • Accepted September 26, 2021
  • First published October 20, 2021.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.